Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

chron.com - Royalty Pharma: Q2 Earnings Snapshot
Royalty Pharma: Q2 Earnings Snapshot
Chron

NEW YORK (AP) — NEW YORK (AP) — Royalty Pharma (RPRX) on Wednesday reported second-quarter profit of $18 million. On a per-share basis, the New York-based company said it had net income of 3 cents. Earnings, adjusted for non-recurring…

seekingalpha.com - Wolf Report - Royalty Pharma: At The Right P/E, I'm In (But Not Here) (NASDAQ:RPRX)
Royalty Pharma: At The Right P/E, I'm In (But Not Here) (NASDAQ:RPRX)
Seeking Alpha

Royalty Pharma is a market-leading pharmaceutical royalty company with a unique capital allocation model and a 60% industry share. RPRX offers exposure to blockbuster drug revenues with diversified risk but faces concentration in Vertex and lumpy…

afr.com - Michael Smith - Mayne Pharma investors push for break-up after blocked takeover bid
Mayne Pharma investors push for break-up after blocked takeover bid
Australian Financial Review

Mayne Pharma investors are calling for the sale of its women's health and dermatology businesses in the US, after the federal government's decision to block a takeover of the Adelaide-based company last year left them nursing heavy losses. Key…

indianexpress.com - Express News Service - 3 workers killed, 2 injured in chemical leak at Karnataka pharma factory
3 workers killed, 2 injured in chemical leak at Karnataka pharma factory
The Indian Express

2 min read Bengaluru Make us preferred source on Google Three workers were killed and two others were injured after a chemical leak at a pharmaceutical manufacturing unit in the Kadechur-Badiala industrial area of Karnataka's Yadgir district early…

thehindu.com - The Hindu Bureau - Aurobindo Pharma Q1 net rises 25% to ₹1,032 cr; approves merger of three arms
Aurobindo Pharma Q1 net rises 25% to ₹1,032 cr; approves merger of three arms
The Hindu

Generic drugmaker Aurobindo Pharma reported a 25.2% year-on-year (YoY) increase in consolidated net profit to ₹1,032 crore in the June quarter FY27. The higher net profitability came on a 16.3% YoY increase in revenue from operations to…

thehindubusinessline.com - Gland Pharma, Neuland Laboratories team up for sterile API manufacturing
Gland Pharma, Neuland Laboratories team up for sterile API manufacturing
BusinessLine

Gland Pharma and Neuland Laboratories have entered into a long-term a contract development and manufacturing organisation (CDMO) partnership under which Gland will establish a sterile manufacturing suite for active pharmaceutical ingredients (APIs)…

marketbeat.com - NewAmsterdam Pharma Maps Obicetrapib Strategy as PREVAIL Interim Nears
NewAmsterdam Pharma Maps Obicetrapib Strategy as PREVAIL Interim Nears
MarketBeat

NewAmsterdam Pharma NASDAQ: NAMS used its annual Investor Day to outline its cardiovascular outcomes strategy for obicetrapib, provide updates on additional clinical programs and discuss commercial preparations ahead of a potential European launch.

marketbeat.com - Urogen Pharma (NASDAQ:URGN) Stock Price Up 9.1% - Here's Why
Urogen Pharma (NASDAQ:URGN) Stock Price Up 9.1% - Here's Why
MarketBeat

Urogen Pharma (NASDAQ:URGN - Get Free Report)'s share price was up 9.1% during mid-day trading on Wednesday. The company traded as high as $43.99 and last traded at $43.56. Approximately 193,743 shares were traded during mid-day trading, a decline…

globenewswire.com - ALK Abello - Market launch of the nasal adrenaline spray, neffy, for treatment of adults and children with severe allergies in Canada
Market launch of the nasal adrenaline spray, neffy, for treatment of adults and children with severe allergies in Canada
GlobeNewswire

ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced the market launch of neffy2 mg in Canada following the approval by Health Canada in April 2026. The launch of this first ever nasal adrenaline spray for emergency treatment of anaphylaxis…

marketbeat.com - Lazard Asset Management LLC Sells 108,947 Shares of Royalty Pharma PLC $RPRX
Lazard Asset Management LLC Sells 108,947 Shares of Royalty Pharma PLC $RPRX
MarketBeat

Lazard Asset Management LLC cut its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 81.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,163 shares of…

marketbeat.com - Cooper Investors PTY Ltd. Has $9.21 Million Stock Position in Royalty Pharma PLC $RPRX
Cooper Investors PTY Ltd. Has $9.21 Million Stock Position in Royalty Pharma PLC $RPRX
MarketBeat

Cooper Investors PTY Ltd. reduced its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 22.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The…

forbes.com - Caroline Petit - Medical Data Needs Its Own Accountability Chain
Medical Data Needs Its Own Accountability Chain
Forbes

Caroline Petit, Global Director, Advertising and Promotions, Regulatory Affairs at Takeda. Medical data is not ordinary data. It contains information about a person's body, health, identity, risks and future, and in an AI-driven healthcare…

thehindubusinessline.com - Nifty Prediction Today - August 5, 2026: Nifty futures: Might see intraday rally
Nifty Prediction Today - August 5, 2026: Nifty futures: Might see intraday rally
BusinessLine

Nifty 50 began today's session with a gap-up at 24,669 versus yesterday's close of 24,615. The index is now trading at 24,600. The advance/decline ratio stands at 24/26. L&T, up 1.5 per cent, is the top gainer followed by InterGlobe Aviation, up…

swissinfo.ch - swissinfo.ch - Sandoz legal costs weigh down profits
Sandoz legal costs weigh down profits
www.swissinfo.ch

Profits slumped to $109 million after the company was fined around $480 million in the United States. The Rhine-based multinational had previously set aside provisions for this anticipated legal cost. The half-yearly report published on Wednesday…

thehindubusinessline.com - KS Badri Narayanan - Q1 Results 05th Aug Live: Power Grid, Cummins India, GE Vernova, Aurobindo Pharma, PB Fintech, Biocon, Berger Paints, Aster DM, Navin Fluorine, Whirlpool Q1 results Today, Bharti Airtel, Graphite, Godrej Prop, Dr Agarwal's gain, ONGC, BSE, Marico, Nykaa & Kalyan Jewellers decline after Q1
Q1 Results 05th Aug Live: Power Grid, Cummins India, GE Vernova, Aurobindo Pharma, PB Fintech, Biocon, Berger Paints, Aster DM, Navin Fluorine, Whirlpool Q1 results Today, Bharti Airtel, Graphite, Godrej Prop, Dr Agarwal's gain, ONGC, BSE, Marico, Nykaa & Kalyan Jewellers decline after Q1
BusinessLine

Q1 Results Today, 5th August 2026 Live Updates: Get real-time Q1 FY27 earnings updates, profit growth, revenue numbers and management outlook from Aegis Vopak Terminals, AJAX Engineering, Allcargo Logistics, All Time Plastics, Amanta Healthcare…

Receive a Daily briefing on Pharma Industry News

Get Started